Rome IV - Child Functional Nausea and Vomiting

Why use it

Nausea and vomiting are among the most common gastrointestinal complaints in children and adolescents presenting to primary care and specialty clinics. A large proportion of these patients have no identifiable organic cause after appropriate evaluation. Applying Rome IV criteria enables a positive diagnosis based on symptom pattern rather than a diagnosis of exclusion, reduces unnecessary investigations, facilitates earlier initiation of biopsychosocial treatment, and aligns clinical practice with current evidence on the gut-brain axis in pediatric functional gastrointestinal disorders.

About

The Rome IV criteria for Functional Nausea and Vomiting Disorders in children (category H2b) were established by the Rome Foundation Pediatric Committee and published in Gastroenterology in 2016. These criteria apply to children and adolescents aged 4–18 years and replace the Rome III categories for these conditions. Rome IV H2b is divided into two distinct diagnoses: H2b1 (Functional Nausea) and H2b2 (Functional Vomiting). Functional Nausea is characterised by bothersome nausea as the predominant symptom, occurring at least twice per week, not consistently associated with meals, not relieved by vomiting, and not explained by another medical condition, present for at least 2 months. Functional Vomiting requires an average of one or more vomiting episodes per week, absence of self-induced vomiting, absence of eating disorder criteria, absence of rumination syndrome criteria, and no organic explanation, also present for at least 2 months. Both diagnoses require appropriate medical evaluation to exclude structural, metabolic, neurological, and other organic etiologies. These conditions are distinct from Cyclic Vomiting Syndrome (H2a) and Rumination Syndrome (H2c), which have separate Rome IV criteria. Functional Nausea and Vomiting disorders are associated with significant quality-of-life impairment, school absenteeism, and psychological comorbidities including anxiety and depression.

When to use

• Children aged 4–18 years with recurrent nausea or vomiting as the predominant complaint
• After appropriate evaluation has excluded structural causes (e.g., intestinal obstruction, gastroparesis on gastric emptying study), metabolic causes (e.g., thyroid, adrenal, renal disease), neurological causes (e.g., raised ICP, vestibular disease), and infectious etiologies
• When nausea is not consistently meal-related and is not secondary to pain, anxiety, or another primary diagnosis
• Distinguishing Functional Nausea/Vomiting from Cyclic Vomiting Syndrome (episodic, stereotyped pattern) and Rumination Syndrome (regurgitation shortly after meals)
• Guiding the conversation with families about a biopsychosocial model of care and avoiding diagnostic odyssey
• NOT to be applied in children under 4 years of age — infant/toddler Rome IV criteria apply separately (G series)

Formula

Pearls & pitfalls

• The key distinction between Functional Nausea (H2b1) and Functional Vomiting (H2b2) is that nausea is the predominant symptom in the former — vomiting may be absent or infrequent. In H2b2, vomiting is the defining feature.
• Functional Nausea must be "not consistently associated with meals" — meal-triggered nausea or postprandial distress is more consistent with Functional Dyspepsia (H2d) or Gastroparesis.
• A critical criterion for H2b2 is the exclusion of self-induced vomiting and eating disorder criteria — always screen for anorexia nervosa and bulimia nervosa in this age group before applying the Rome IV label.
• Both diagnoses require symptoms for at least 2 months — acute nausea/vomiting in children does not meet Rome IV criteria and should be evaluated for infectious, metabolic, and other acute causes.
• Anxiety and school avoidance are extremely common in children with functional nausea — in several studies, 50–80% of children with functional nausea meet criteria for an anxiety disorder. Always ask about school attendance.
• Gastroparesis can mimic functional nausea/vomiting — a gastric emptying scintigraphy study (4-hour solid meal protocol) should be considered if symptoms are predominantly postprandial, there is early satiety, or no response to initial treatment.
• Rome IV removed the requirement that symptoms "cannot be attributed to other functional gastrointestinal disorders" — a patient can now carry multiple co-occurring functional diagnoses.
• Cyclic Vomiting Syndrome (H2a) must be excluded before diagnosing H2b2 — CVS features a stereotyped, episodic pattern (episodes identical in onset and symptoms), not chronic weekly vomiting.
• The Rome IV Pediatric criteria can be applied by the clinician without a formal questionnaire — the diagnostic tool is the structured clinical history. Validated questionnaires (PGSYMQ, PGWB) can supplement but are not required for diagnosis.

Next steps

Functional Nausea (H2b1) diagnosed: Explain the diagnosis using age-appropriate language and the gut-brain axis model. Assess for anxiety, depression, school avoidance, and stressful life events — these are common comorbidities and drivers of symptom severity. First-line: psychological therapies including cognitive behavioural therapy (CBT) and gut-directed hypnotherapy have the best evidence. Consider referral to a pediatric psychologist or psychiatrist. Pharmacological options are limited by evidence: low-dose cyproheptadine (weight-based dosing) or tricyclic antidepressants (amitriptyline 0.2–0.5 mg/kg at night) may be trialled in moderate-to-severe cases under specialist guidance. Ensure nutritional adequacy. Regular school attendance should be maintained. Functional Vomiting (H2b2) diagnosed: Similar approach — psychoeducation and biopsychosocial model. Identify and treat comorbid anxiety, which is particularly common. Antiemetics (ondansetron, domperidone) may provide short-term symptom relief but are not curative and should not be used long-term. CBT addressing health anxiety and avoidance behaviours is the mainstay of treatment. Ensure no occult eating disorder is missed — screen with validated tools (SCOFF, EDE-Q adapted for age). Neither diagnosis: review whether organic causes have been adequately excluded, and reassess symptom pattern for other Rome IV diagnoses (Cyclic Vomiting Syndrome, Rumination Syndrome, Gastroparesis).

Evidence

Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional Disorders: Children and Adolescents. Gastroenterology. 2016;150(6):1456-1468.e2. PMID:27144632. This is the primary Rome IV reference establishing H2b1 and H2b2 criteria. Kovacic K et al. Functional nausea in children: a multicenter case-control study. Pediatrics. 2014;134(3):e854-61. PMID:25092938. Demonstrates high psychological comorbidity and impact on QoL. Friesen CA et al. Practical Management of Functional Abdominal Pain and Related Disorders in Children and Adolescents. J Pediatr Gastroenterol Nutr. 2020;70(3):275-286 — systematic review and management guidelines for pediatric functional GI disorders.

References

1. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional Disorders: Children and Adolescents. Gastroenterology. 2016;150(6):1456-1468.e2. — link
2. Kovacic K, Williams S, Li BU, Chelimsky G, Miranda A. High prevalence of nausea in children with pain-associated functional gastrointestinal disorders: are Rome criteria sufficient? J Pediatr Gastroenterol Nutr. 2013;57(3):311-315. — link
3. Drossman DA (ed). Rome IV: Functional Gastrointestinal Disorders. 4th ed. Raleigh, NC: Rome Foundation; 2016. — link
4. Friesen CA, Schurman JV, Colombo JM, Abdel-Rahman SM. Practical Management of Functional Abdominal Pain and Related Disorders in Children and Adolescents. J Pediatr Gastroenterol Nutr. 2020;70(3):275-286. — link